Pallas Health Tirzepatide Review: The 12-Week Block, Priced Honestly (2026)

Pallas Health charges $179 for your first four weeks of compounded tirzepatide, then $897 every twelve weeks — the only cadence it sells. Pallas calls that "$299/month average", and the average is arithmetic rather than a bill anyone receives. Prices verified on Pallas Health's own site on August 28, 2026. Pallas is an affiliate partner: we earn a commission if you start care through our links, at no extra cost to you — see our disclosure.

The number that matters is 4.33, not 4

A twelve-week block sounds like a quarter, and a quarter sounds like three months. It is neither. A year holds 4.33 twelve-week cycles, not four — so a full year on the standing block is about $3,881, not the $3,588 you get by multiplying $897 by four. Add the discounted first cycle and a first year runs roughly $3,163.

Set against the "$299/month average" Pallas publishes, twelve of those months would be $3,588. The gap is not large, but it runs the wrong way: the average understates the year. Any program that bills on a cycle shorter than a calendar quarter has this arithmetic in it, and almost none of them show it.

What you are actually buying

Pallas is a cash-pay telehealth service selling compounded semaglutide and compounded tirzepatide. A U.S.-licensed clinician reviews an online intake and, where appropriate, the medication ships from a U.S. pharmacy. Two things distinguish it from most of the field.

The first is that the price is on the public site before any intake. You can read $179, $897 and the twelve-week cadence without handing over a medical history, which a large share of this market will not let you do. The second is a Spanish-language site alongside the English one — rare in compounded GLP-1 telehealth, and a real access difference for Spanish-speaking patients who otherwise have to navigate an intake in a second language.

The semaglutide line runs the same shape at a lower price: $139 for the first month, then $597 every twelve weeks, which Pallas averages to $199/month.

The compounded-versus-brand distinction

Pallas dispenses compounded tirzepatide, not Zepbound or Mounjaro. Compounded tirzepatide is prepared by a pharmacy; it is not an FDA-approved finished drug, it is not a generic of the brand, and it was not the product tested in the pivotal trials. What those trials established is the ceiling people cite when they talk about this molecule: in the 72-week SURMOUNT-1 trial, adults without diabetes lost on average roughly 15% to 21% of body weight across the 5–15 mg doses, against about 3% on placebo¹. Against semaglutide in SURMOUNT-5, tirzepatide produced roughly 20% versus 14%². Those results came from the brand molecule at FDA-approved doses.

Pallas does not name its compounding pharmacy or state whether it is a 503A pharmacy or a 503B outsourcing facility. That is the ordinary standard in this market rather than a failing unique to Pallas, but it is worth asking before you pay, and our trust and verification index records which programs do name one.

Who this suits, and who it does not

The block cadence is the whole decision. If you are confident you want three months of treatment, paying $897 once is simpler than three separate charges and the first cycle at $179 makes starting cheap. If you are not sure the medication will suit you, a program with a genuine month-to-month rung lets you stop after four weeks for less money at risk — and several do, at prices in the same range. Our ranking sorted by published monthly price shows which, with the term printed beside every figure.

The honest verdict: Pallas prices openly, in public, in two languages, and tells you the amount it will actually charge — which is more than much of this field manages. What it does not offer is a way to spend less than $897 to find out whether you want to continue past the first cycle.

The bottom line

$179 for four weeks, then $897 every twelve. Around $3,163 in a first year and about $3,881 a year after that, because a year is 4.33 cycles. No monthly option exists. The medication is compounded rather than FDA-approved, and no pharmacy is named. If the block suits how you want to buy, the pricing is unusually transparent; if it does not, the shortest commitment here is three months.